Targeting LIN28: A New Hope in Prostate Cancer Theranostics

Garima Shrivastava(Indian Institute of Technology Delhi), Murtaza M. Tambuwala(Ras al-Khaimah Medical and Health Sciences University), Kenneth Lundstorm(Sensei Biotherapeutics (United States)), Niraj Kumar Jha(Lovely Professional University), Pritam Kumar Panda(Uppsala University), Harish Dureja(Maharshi Dayanand University), Abdulmajeed G. Almutary(Abu Dhabi University), Alaa A. A. Aljabali(Yarmouk University), Kamal Dua(University of Technology Sydney), Madhur D. Shastri(University of Tasmania), Shakti D. Shukla(University of Technology Sydney), Abdullah M. Alnuqaydan(Qassim University), Kazuo Takayama(Tokyo Medical University), Parteek Prasher(University of Petroleum and Energy Studies), Marzieh Lotfi(Shahid Sadoughi University of Medical Sciences and Health Services), Rohit Goyal(Indo Soviet Friendship College of Pharmacy), Poonam Negi(Chitkara University), Vijay Mishra(Lovely Professional University), Krishnan Anand(University of the Free State), Ángel Serrano‐Aroca(Valencia Catholic University Saint Vincent Martyr), Dinesh Kumar Chellappan(Ajman University), Debmalya Barh(Institute of Bioinformatics and Applied Biotechnology), Hamid A. Bakshi(Mayo Clinic), Ritesh M. Pabari(Royal College of Surgeons in Ireland), Paul A. McCarron(Queen's University Belfast), Gaurav Gupta(Gyan Vihar University), Seyed Hossein Shahcheraghi(Shahid Sadoughi University of Medical Sciences and Health Services), Nitin B. Charbe, Bojlul Bahar(University of Lancashire)
Future Oncology
July 15, 2021
Cited by 18


Related Papers